BaMedFounder

17
Days Left
8 Donors PLEDGED
$2,550

3% OF $75,000 TARGETED

This project will only be funded if at least $56,250 is pledged by Mar 17 2015.

Incentive: Rewards

2 DONORS
PLEDGE $50 OR MORE

Letter of appreciation

Unlimited
2 DONORS
PLEDGE $100 OR MORE

1 Epiditi® free of charge for self use. Rewards will be sent upon the commercial release of the device.

Unlimited
2 DONORS
PLEDGE $500 OR MORE

5 Epiditi® free of charge for self-use and the use of friends having similar urological problems. Rewards will be sent upon the commercial release of the device.

Unlimited
2 DONORS
PLEDGE $1000 OR MORE

10 Epiditi® delivered to urological office of your choice to be given free of charge to patients with financial difficulties. Rewards will be sent upon the commercial release of the device.

Unlimited
0 DONORS
PLEDGE $2500 OR MORE

25 Epiditi® delivered to urological office of your choice to be given free of charge to patients with financial difficulties. Rewards will be sent upon the commercial release of the device.

Unlimited
  • Quality of Life
  • Short Hills, New Jersey, United States
  • Oct 11 2013
  • ID 303

SHARE

Proposed Product

Epiditi® is a patented thermal treatment device for injuries/diseases to the male genitalia. Epiditi® applies cooling and/or heating treatment directly to the scrotal area. It completely envelops the scrotal sac and the penile area. The purpose of the Epiditi® is to provide medically targeted therapy to mitigate post operative trauma, including pre existing penile torsion and/or twisting of the scrotal sac, post operative trauma complications of swelling, bruising, inflammation, hemorrhaging, pain and like diseases of the scrotum and/or penis.

Current Solutions

Ice therapy in the form of ice bags lacking any shape or conforming dimension is the preferred form of treatment for injuries to the scrotal area. In some cases physicians use a frozen bag of peas. The problem is that uniform application and cooling cannot be achieved using the present outdated remedy. Epiditi® applies conforming and uniform treatment to the male genetillia and at the same time uplifts the area to relieve stress on the effected organs. Up until now it has not been possible to apply uniform cooling/heating and relieve pressure to the affected areas because of the limitations of our technology.

Market Need

There is a large unfulfilled need for a device to prevent and treat urological diseases in today’s health care facilities. While outpatient care is the fastest growing segment of the healthcare industry, there is a large percentage of patients each year who require extended hospitalization time. Complications from urological injuries/diseases can seriously impede recovery time and raise the cost of overall health care. There is a significant number of individuals who suffer from urological diseases of one form or another. Patients who suffer from these diseases need to reduce the recovery time so that they can return to their normal life and resume activities. Finally, there are those individuals who desire alternative methods of seeking good health and solving existing medical problems. The use of ice in alternative medicine has existed for decades and more people are using non-traditional methods as the popularity of such practices becomes more mainstream. This innovation applies form fitted ice therapy to the scrotal area in the treatment of a variety of diseases and ailments.

Importance

There is currently no specific medical device for the targeted treatment of male urological injuries in the medical market place. Ice therapy in the form of ice bags lacking any shape or conforming dimension is the preferred form of treatment for injuries to the scrotal area. In some cases physicians use a frozen bag of peas. The problem is that uniform application and cooling/heating cannot be achieved using the present outdated technology. Epiditi® applies a conforming and uniform treatment to the male genetillia; and at the same time uplifts the area to relieve stress on the effected organs. Up until now it has not been possible to apply uniform cooling/heating and relieve pressure to the affected areas because of the limitations of our technology.

Stage of Development

The following intellectual property rights to the Epiditi® have been secured: US Design Patent Issued number: D669,995S European Union Patent: Registered No. 002108183-0001 Utility Patent: Pending Multiple Trademarks and Copyrights including: Epiditi® Reg. No, 4,231,366 Cool the Jewels!® Reg. No. 4,302,809 The Epiditi® is ready to go into production. In order to go into production, dyes have to be made to produce the product. Boxing and packaging design as well as instructions for use have been completed.

Intellectual Property

Mike Gallen, CEO of Gallen Technology Corporation is the owner of the following Intellectual Property Rights, and has assigned the Intellectual Property Rights to Gallen Technology Corporation for the purpose of manufacturing and distributing Epiditi®. US Design Patent Issued number: D669,995S European Union Patent: Registered No. 002108183-0001 Utility Patent: Pending Multiple Trademarks and Copyrights including: Epiditi® Reg. No, 4,231,366 Cool the Jewels!® Reg. No. 4,302,809

Use of Funds

1. The funds will be used to manufacture the dyes necessary to produce the Epiditi®. Production of the Epiditi® will begin with the intended creation of 5,000 units. 2. Contact Board Certified Urologists announcing launch of Epiditi®. 3. Launch Epiditi® for direct sales through our website. 4. Contact Emergency Room administrations, Quick Care Facilities, purchasing agents of chain pharmacies, and independent pharmacies announcing the use and availability of Epiditi®. 5. Create infomercial for TV spots in local cable markets for over the counter purchases.

Project By:

Mike G.

Gallen Technology Corporation is in research and development of medical product devices. www.gallentechnology.com

Attachments:

  • Anonymous

    Anonymous

    United States

    489 days ago

  • Anonymous

    Anonymous

    United States

    489 days ago

  • Anonymous

    Anonymous

    United States

    489 days ago

  • Anonymous

    Anonymous

    United States

    494 days ago

  • Anonymous

    Anonymous

    United States

    494 days ago

  • Anonymous

    Anonymous

    United States

    494 days ago

  • Anonymous

    Anonymous

    United States

    494 days ago

  • Anonymous

    Anonymous

    United States

    494 days ago

Comments

You must LOGIN or SIGN UP to post questions and comment.